KARBE FRANK 4
4 · Better Therapeutics, Inc. · Filed Apr 12, 2023
Insider Transaction Report
Form 4
KARBE FRANK
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2023-04-10$0.82/sh+242,424$200,000→ 292,424 total
Footnotes (1)
- [F1]On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 242,424 shares of Issuer common stock on April 10, 2023 for $0.825 per share.